Addario Lung Cancer Medical Institute
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$2,244,730
Investments
38%
Cash & Equivalents
31%
Prepaid Expenses
26%
Other Assets
4%
Receivables (Non-Related)
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$551,191
Deferred Revenue
52%
Payables & Accruals
32%
Other Liabilities
16%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$559,655
$695,719
+24%
Receivables (Non-Related)
$51,862
$19,793
-62%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$56,273
$583,783
+937%
Investments
$815,025
$856,982
+5%
Property, Plant, & Equipment (net)
$866
$482
-44%
Other Assets
$6,962
$87,971
+1164%
Total Assets
$1,490,643
$2,244,730
+51%
Liabilities
2023
2024
Change
Payables & Accruals
$115,850
$174,504
+51%
Grants Payable
-
-
-
Deferred Revenue
-
$287,846
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$6,962
$88,841
+1176%
Total Liabilities
$122,812
$551,191
+349%
Net assets
2023
2024
Change
Restricted Net Assets
$416,939
$1,537,154
+269%
Unrestricted Net Assets
$950,892
$156,385
-84%
Net assets
2023
2024
Change
Net assets
+$1,367,831
+$1,693,539
+24%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)